ArticleDrugs in R&D2017

Identification of a Syndrome Class of Neuropsychiatric Adverse Reactions to Mefloquine from Latent Class Modeling of FDA Adverse Event Reporting System Data.

Remington L Nevin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.